| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.47 | 0.058 | 0.47 | Analgesic | 0.47 0.058 DBMET03652 0.232 0.2 DBMET03654 0.387 0.09 DBMET03655 0.411 0.08 DBMET03657 0.307 0.136 DBMET03656 | ||
| 0.373 | 0.071 | 0.373 | Toll-Like receptor 7 agonist | 0.373 0.071 DBMET03652 0.343 0.085 DBMET03654 0.329 0.093 DBMET03655 0.251 0.147 DBMET03657 | ||
| 0.367 | 0.074 | 0.367 | Toll-Like receptor agonist | 0.367 0.074 DBMET03652 0.335 0.09 DBMET03654 0.325 0.096 DBMET03655 0.244 0.153 DBMET03657 | ||
| 0.408 | 0.135 | 0.445 | Antiinflammatory | 0.408 0.135 DBMET03652 0.445 0.113 DBMET03654 0.316 0.201 DBMET03655 0.333 0.186 DBMET03657 | DBMET03654 | |
| 0.304 | 0.048 | 0.334 | HERG channel blocker | 0.304 0.048 DBMET03652 0.207 0.087 DBMET03654 0.334 0.041 DBMET03655 | DBMET03655 | |
| 0.237 | 0.006 | 0.391 | Phosphatidylinositol 3-kinase delta inhibitor | 0.237 0.006 DBMET03652 0.125 0.015 DBMET03654 0.391 0.004 DBMET03655 0.154 0.01 DBMET03657 0.291 0.005 DBMET03656 | DBMET03655 | |
| 0.26 | 0.062 | 0.26 | Potassium channel blocker | 0.26 0.062 DBMET03652 0.147 0.138 DBMET03654 0.238 0.072 DBMET03655 | ||
| 0.253 | 0.062 | 0.317 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.253 0.062 DBMET03652 0.215 0.128 DBMET03654 0.296 0.027 DBMET03655 0.268 0.046 DBMET03657 0.317 0.019 DBMET03656 | DBMET03656 | |
| 0.301 | 0.115 | 0.301 | Antiobesity | 0.301 0.115 DBMET03652 0.22 0.186 DBMET03655 0.282 0.13 DBMET03657 | ||
| 0.204 | 0.024 | 0.204 | Epidermal growth factor receptor kinase inhibitor | 0.204 0.024 DBMET03652 0.122 0.071 DBMET03654 0.194 0.028 DBMET03655 0.192 0.028 DBMET03657 0.176 0.034 DBMET03656 | ||
| 0.188 | 0.017 | 0.188 | EphA2 antagonist | 0.188 0.017 DBMET03652 0.119 0.055 DBMET03654 0.179 0.019 DBMET03655 0.167 0.023 DBMET03657 0.15 0.03 DBMET03656 | ||
| 0.232 | 0.062 | 0.239 | ErbB-1 antagonist | 0.232 0.062 DBMET03652 0.239 0.057 DBMET03655 0.218 0.072 DBMET03657 0.222 0.069 DBMET03656 | DBMET03655 | |
| 0.238 | 0.073 | 0.247 | Potassium channel (Voltage-sensitive) blocker | 0.238 0.073 DBMET03652 0.157 0.131 DBMET03654 0.247 0.068 DBMET03655 | DBMET03655 | |
| 0.189 | 0.057 | 0.189 | Antipruritic | 0.189 0.057 DBMET03652 | ||
| 0.137 | 0.007 | 0.137 | CC chemokine 2 receptor antagonist | 0.137 0.007 DBMET03652 0.104 0.012 DBMET03657 | ||
| 0.152 | 0.023 | 0.152 | Epidermal growth factor antagonist | 0.152 0.023 DBMET03652 0.083 0.061 DBMET03654 0.141 0.025 DBMET03655 0.135 0.027 DBMET03657 0.121 0.032 DBMET03656 | ||
| 0.193 | 0.071 | 0.193 | Tyrosine kinase inhibitor | 0.193 0.071 DBMET03652 0.185 0.074 DBMET03655 0.157 0.086 DBMET03657 0.14 0.095 DBMET03656 | ||
| 0.142 | 0.022 | 0.201 | Leucine-rich repeat kinase 2 inhibitor | 0.142 0.022 DBMET03652 0.201 0.01 DBMET03655 0.092 0.048 DBMET03656 | DBMET03655 | |
| 0.174 | 0.075 | 0.193 | MAP kinase kinase 5 inhibitor | 0.174 0.075 DBMET03652 0.188 0.048 DBMET03655 0.178 0.067 DBMET03657 0.193 0.041 DBMET03656 | DBMET03656 | |
| 0.142 | 0.052 | 0.345 | TRKB antagonist | 0.142 0.052 DBMET03652 0.345 0.007 DBMET03655 0.101 0.099 DBMET03657 0.256 0.016 DBMET03656 | DBMET03655 | |
| 0.147 | 0.06 | 0.215 | Phosphodiesterase inhibitor | 0.147 0.06 DBMET03652 0.118 0.084 DBMET03654 0.215 0.03 DBMET03655 0.135 0.069 DBMET03656 | DBMET03655 | |
| 0.131 | 0.046 | 0.288 | Granulocyte macrophage colony stimulating factor antagonist | 0.131 0.046 DBMET03652 0.288 0.009 DBMET03655 0.126 0.049 DBMET03656 | DBMET03655 | |
| 0.123 | 0.04 | 0.144 | CDK/cyclin complex inhibitor | 0.123 0.04 DBMET03652 0.144 0.032 DBMET03655 0.108 0.047 DBMET03657 0.122 0.04 DBMET03656 | DBMET03655 | |
| 0.148 | 0.065 | 0.369 | Tyrosine-protein kinase receptor antagonist | 0.148 0.065 DBMET03652 0.369 0.011 DBMET03655 0.24 0.029 DBMET03656 | DBMET03655 | |
| 0.112 | 0.029 | 0.112 | Janus tyrosine kinase 3 inhibitor | 0.112 0.029 DBMET03652 0.103 0.032 DBMET03657 | ||
| 0.127 | 0.046 | 0.196 | Ephrin antagonist | 0.127 0.046 DBMET03652 0.196 0.025 DBMET03655 0.109 0.056 DBMET03657 0.164 0.033 DBMET03656 | DBMET03655 | |
| 0.124 | 0.043 | 0.139 | Cyclin-dependent kinase 9 inhibitor | 0.124 0.043 DBMET03652 0.139 0.038 DBMET03655 0.105 0.057 DBMET03657 0.113 0.05 DBMET03656 | DBMET03655 | |
| 0.113 | 0.033 | 0.152 | ErbB-3 antagonist | 0.113 0.033 DBMET03652 0.152 0.018 DBMET03655 0.092 0.048 DBMET03657 0.12 0.029 DBMET03656 | DBMET03655 | |
| 0.147 | 0.072 | 0.191 | Growth factor antagonist | 0.147 0.072 DBMET03652 0.191 0.049 DBMET03655 0.132 0.082 DBMET03657 0.168 0.059 DBMET03656 | DBMET03655 | |
| 0.112 | 0.037 | 0.112 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.112 0.037 DBMET03652 0.1 0.045 DBMET03655 0.093 0.052 DBMET03657 0.085 0.063 DBMET03656 | ||
| 0.113 | 0.038 | 0.141 | mTOR complex 1 inhibitor | 0.113 0.038 DBMET03652 0.141 0.014 DBMET03655 0.101 0.061 DBMET03657 0.126 0.023 DBMET03656 | DBMET03655 | |
| 0.174 | 0.101 | 0.244 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.174 0.101 DBMET03652 0.244 0.045 DBMET03655 0.171 0.105 DBMET03657 0.24 0.047 DBMET03656 | DBMET03655 | |
| 0.139 | 0.068 | 0.139 | Cyclin-dependent kinase 7 inhibitor | 0.139 0.068 DBMET03652 0.119 0.085 DBMET03655 0.132 0.074 DBMET03657 0.105 0.096 DBMET03656 | ||
| 0.093 | 0.024 | 0.118 | Purinergic P2 antagonist | 0.093 0.024 DBMET03652 0.118 0.016 DBMET03655 0.07 0.039 DBMET03657 0.087 0.028 DBMET03656 | DBMET03655 | |
| 0.084 | 0.016 | 0.138 | Phosphatidylinositol 3-kinase beta inhibitor | 0.084 0.016 DBMET03652 0.049 0.035 DBMET03654 0.138 0.008 DBMET03655 0.057 0.026 DBMET03657 0.091 0.014 DBMET03656 | DBMET03655 | |
| 0.101 | 0.035 | 0.101 | Vanilloid antagonist | 0.101 0.035 DBMET03652 0.097 0.037 DBMET03655 0.078 0.049 DBMET03657 0.075 0.051 DBMET03656 | ||
| 0.148 | 0.086 | 0.236 | Polo-like kinase-3 inhibitor | 0.148 0.086 DBMET03652 0.236 0.029 DBMET03655 0.143 0.093 DBMET03657 0.23 0.031 DBMET03656 | DBMET03655 | |
| 0.154 | 0.098 | 0.296 | CDC-like kinase 4 inhibitor | 0.154 0.098 DBMET03652 0.296 0.033 DBMET03655 0.242 0.049 DBMET03656 | DBMET03655 | |
| 0.106 | 0.054 | 0.106 | Hedgehog signaling inhibitor | 0.106 0.054 DBMET03652 0.096 0.072 DBMET03657 | ||
| 0.076 | 0.025 | 0.076 | Cyclin-dependent kinase 6 inhibitor | 0.076 0.025 DBMET03652 0.064 0.036 DBMET03655 0.067 0.033 DBMET03657 0.054 0.048 DBMET03656 | ||
| 0.128 | 0.082 | 0.291 | Ribosomal protein S6 kinase inhibitor | 0.128 0.082 DBMET03652 0.291 0.013 DBMET03655 0.113 0.099 DBMET03657 0.274 0.015 DBMET03656 | DBMET03655 | |
| 0.073 | 0.029 | 0.073 | CDK4/cyclin D1 inhibitor | 0.073 0.029 DBMET03652 0.07 0.031 DBMET03655 0.07 0.031 DBMET03657 0.065 0.034 DBMET03656 | ||
| 0.082 | 0.037 | 0.095 | MAP kinase 7 inhibitor | 0.082 0.037 DBMET03652 0.095 0.012 DBMET03655 0.077 0.054 DBMET03657 0.09 0.02 DBMET03656 | DBMET03655 | |
| 0.067 | 0.028 | 0.072 | Bruton tyrosine kinase inhibitor | 0.067 0.028 DBMET03652 0.072 0.024 DBMET03655 0.064 0.031 DBMET03657 0.067 0.028 DBMET03656 | DBMET03655 | |
| 0.077 | 0.038 | 0.077 | Phosphodiesterase 4B inhibitor | 0.077 0.038 DBMET03652 | ||
| 0.084 | 0.045 | 0.084 | Janus tyrosine kinase 2 inhibitor | 0.084 0.045 DBMET03652 0.079 0.048 DBMET03657 | ||
| 0.204 | 0.165 | 0.292 | Angiogenesis inhibitor | 0.204 0.165 DBMET03652 0.292 0.097 DBMET03655 0.222 0.146 DBMET03656 | DBMET03655 | |
| 0.114 | 0.077 | 0.173 | Cyclin-dependent kinase inhibitor | 0.114 0.077 DBMET03652 0.165 0.049 DBMET03655 0.119 0.074 DBMET03657 0.173 0.046 DBMET03656 | DBMET03656 | |
| 0.096 | 0.061 | 0.115 | CDK2/cyclin A inhibitor | 0.096 0.061 DBMET03652 0.115 0.046 DBMET03655 0.088 0.07 DBMET03657 0.102 0.056 DBMET03656 | DBMET03655 | |
| 0.071 | 0.036 | 0.085 | Cyclin A inhibitor | 0.071 0.036 DBMET03652 0.085 0.029 DBMET03655 0.057 0.046 DBMET03657 0.071 0.037 DBMET03656 | DBMET03655 | |
| 0.066 | 0.031 | 0.066 | CDK4/cyclin D inhibitor | 0.066 0.031 DBMET03652 0.052 0.05 DBMET03654 0.065 0.032 DBMET03655 0.064 0.033 DBMET03657 0.063 0.035 DBMET03656 | ||
| 0.076 | 0.042 | 0.115 | CDK1/cyclin B1 inhibitor | 0.076 0.042 DBMET03652 0.115 0.023 DBMET03655 0.072 0.046 DBMET03657 0.107 0.026 DBMET03656 | DBMET03655 | |
| 0.089 | 0.057 | 0.089 | Ca(v)2.2 blocker | 0.089 0.057 DBMET03652 | ||
| 0.048 | 0.016 | 0.076 | Somatostatin 4 agonist | 0.048 0.016 DBMET03652 0.038 0.024 DBMET03654 0.076 0.009 DBMET03655 0.042 0.02 DBMET03657 0.062 0.011 DBMET03656 | DBMET03655 | |
| 0.114 | 0.083 | 0.326 | RET inhibitor | 0.114 0.083 DBMET03652 0.326 0.018 DBMET03655 0.285 0.025 DBMET03656 | DBMET03655 | |
| 0.057 | 0.027 | 0.078 | Alpha 1L adrenoreceptor antagonist | 0.057 0.027 DBMET03652 0.078 0.008 DBMET03655 0.05 0.044 DBMET03657 0.067 0.014 DBMET03656 | DBMET03655 | |
| 0.079 | 0.049 | 0.081 | ErbB-2 antagonist | 0.079 0.049 DBMET03652 0.081 0.047 DBMET03655 0.073 0.055 DBMET03657 0.074 0.054 DBMET03656 | DBMET03655 | |
| 0.065 | 0.037 | 0.163 | Phosphatidylinositol kinase inhibitor | 0.065 0.037 DBMET03652 0.163 0.011 DBMET03655 0.098 0.022 DBMET03656 | DBMET03655 | |
| 0.194 | 0.166 | 0.324 | Nootropic | 0.194 0.166 DBMET03652 0.324 0.063 DBMET03655 0.209 0.146 DBMET03656 | DBMET03655 | |
| 0.042 | 0.015 | 0.077 | Purinergic P2X3 antagonist | 0.042 0.015 DBMET03652 0.077 0.005 DBMET03655 0.035 0.023 DBMET03657 0.064 0.007 DBMET03656 | DBMET03655 | |
| 0.153 | 0.127 | 0.309 | EphB2 antagonist | 0.153 0.127 DBMET03652 0.307 0.033 DBMET03655 0.152 0.128 DBMET03657 0.309 0.033 DBMET03656 | DBMET03656 | |
| 0.077 | 0.054 | 0.106 | ErbB-4 antagonist | 0.077 0.054 DBMET03652 0.106 0.037 DBMET03655 0.086 0.048 DBMET03656 | DBMET03655 | |
| 0.104 | 0.084 | 0.281 | TRKA antagonist | 0.104 0.084 DBMET03652 0.281 0.014 DBMET03655 0.198 0.031 DBMET03656 | DBMET03655 | |
| 0.058 | 0.04 | 0.058 | Janus tyrosine kinase 1 inhibitor | 0.058 0.04 DBMET03652 0.054 0.043 DBMET03657 | ||
| 0.065 | 0.048 | 0.159 | Purinergic P2X2 antagonist | 0.065 0.048 DBMET03652 0.159 0.009 DBMET03655 0.153 0.011 DBMET03656 | DBMET03655 | |
| 0.063 | 0.048 | 0.077 | Cyclin-dependent kinase 4 inhibitor | 0.063 0.048 DBMET03652 0.076 0.037 DBMET03655 0.064 0.047 DBMET03657 0.077 0.037 DBMET03656 | DBMET03656 | |
| 0.072 | 0.056 | 0.072 | Potassium channel (Tandem pore domain) blocker | 0.072 0.056 DBMET03652 | ||
| 0.076 | 0.06 | 0.089 | Viral attachment inhibitor | 0.076 0.06 DBMET03652 0.089 0.034 DBMET03654 0.073 0.066 DBMET03657 | DBMET03654 | |
| 0.081 | 0.067 | 0.147 | mTOR complex 2 inhibitor | 0.081 0.067 DBMET03652 0.147 0.009 DBMET03655 0.125 0.015 DBMET03656 | DBMET03655 | |
| 0.035 | 0.024 | 0.035 | Glucose-dependent insulinotropic receptor agonist | 0.035 0.024 DBMET03652 | ||
| 0.062 | 0.051 | 0.063 | Vanilloid 1 antagonist | 0.062 0.051 DBMET03652 0.063 0.051 DBMET03655 | DBMET03655 | |
| 0.03 | 0.02 | 0.044 | Complement C5a chemotactic receptor antagonist | 0.03 0.02 DBMET03652 0.027 0.024 DBMET03654 0.044 0.01 DBMET03655 0.03 0.02 DBMET03656 | DBMET03655 | |
| 0.055 | 0.046 | 0.055 | Protein kinase C iota inhibitor | 0.055 0.046 DBMET03652 0.053 0.049 DBMET03657 | ||
| 0.054 | 0.047 | 0.054 | CDK9/cyclin T1 inhibitor | 0.054 0.047 DBMET03652 0.053 0.047 DBMET03655 | ||
| 0.07 | 0.063 | 0.083 | CC chemokine receptor antagonist | 0.07 0.063 DBMET03652 0.083 0.048 DBMET03654 | DBMET03654 | |
| 0.087 | 0.08 | 0.087 | Alpha 2d adrenoreceptor antagonist | 0.087 0.08 DBMET03652 | ||
| 0.042 | 0.037 | 0.042 | CDK7/cyclin H inhibitor | 0.042 0.037 DBMET03652 | ||
| 0.071 | 0.066 | 0.155 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.071 0.066 DBMET03652 0.155 0.012 DBMET03655 0.15 0.014 DBMET03656 | DBMET03655 | |
| 0.028 | 0.024 | 0.028 | Potassium channel subfamily K member 3 blocker | 0.028 0.024 DBMET03652 | ||
| 0.115 | 0.112 | 0.203 | Src kinase inhibitor | 0.115 0.112 DBMET03652 0.203 0.053 DBMET03655 0.179 0.066 DBMET03656 | DBMET03655 | |
| 0.117 | 0.114 | 0.128 | Aurora-C kinase inhibitor | 0.117 0.114 DBMET03652 0.128 0.087 DBMET03657 | DBMET03657 | |
| 0.055 | 0.052 | 0.092 | Cyclin A2 inhibitor | 0.055 0.052 DBMET03652 0.092 0.027 DBMET03655 0.078 0.034 DBMET03656 | DBMET03655 | |
| 0.027 | 0.026 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.027 0.026 DBMET03652 0.036 0.013 DBMET03655 0.027 0.026 DBMET03656 | DBMET03655 | |
| 0.048 | 0.047 | 0.048 | NMDA 2B receptor antagonist | 0.048 0.047 DBMET03652 0.048 0.047 DBMET03657 | ||
| 0.081 | 0.081 | 0.085 | Polo-like kinase-1 inhibitor | 0.085 0.071 DBMET03655 | DBMET03655 | |
| 0.038 | 0.039 | 0.098 | Phosphodiesterase 10A inhibitor | 0.098 0.01 DBMET03655 0.064 0.019 DBMET03656 | DBMET03655 | |
| 0.038 | 0.039 | 0.098 | Phosphodiesterase X inhibitor | 0.098 0.01 DBMET03655 0.064 0.019 DBMET03656 | DBMET03655 | |
| 0.13 | 0.133 | 0.265 | Clk dual-specificity kinase inhibitor | 0.265 0.049 DBMET03655 0.218 0.069 DBMET03656 | DBMET03655 | |
| 0.047 | 0.051 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.041 DBMET03657 | DBMET03657 | |
| 0.041 | 0.047 | 0.096 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.096 0.017 DBMET03655 0.057 0.032 DBMET03656 | DBMET03655 | |
| 0.039 | 0.046 | 0.067 | Purinergic P2X antagonist | 0.067 0.019 DBMET03655 0.056 0.026 DBMET03656 | DBMET03655 | |
| 0.063 | 0.071 | 0.072 | Glutamate (mGluR) antagonist | 0.072 0.059 DBMET03655 | DBMET03655 | |
| 0.03 | 0.039 | 0.037 | Cyclin D3 inhibitor | 0.037 0.03 DBMET03656 | DBMET03656 | |
| 0.048 | 0.059 | 0.055 | Cyclin H inhibitor | 0.053 0.05 DBMET03655 0.055 0.046 DBMET03656 | DBMET03656 | |
| 0.038 | 0.052 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.037 DBMET03657 | DBMET03657 | |
| 0.043 | 0.059 | 0.08 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.08 0.02 DBMET03655 0.059 0.033 DBMET03656 | DBMET03655 | |
| 0.082 | 0.102 | 0.13 | Glycogen synthase kinase-3 beta inhibitor | 0.13 0.054 DBMET03655 0.103 0.074 DBMET03656 | DBMET03655 | |
| 0.041 | 0.063 | 0.096 | Glutamate (mGluR1) antagonist | 0.096 0.017 DBMET03655 0.064 0.036 DBMET03656 | DBMET03655 | |
| 0.088 | 0.115 | 0.222 | Protein-tyrosine kinase Lyn inhibitor | 0.222 0.038 DBMET03655 0.208 0.043 DBMET03656 | DBMET03655 | |
| 0.07 | 0.098 | 0.144 | Vascular endothelial growth factor 1 antagonist | 0.144 0.043 DBMET03655 0.126 0.051 DBMET03656 | DBMET03655 | |
| 0.152 | 0.181 | 0.252 | MAP-kinase-activated kinase 5 inhibitor | 0.212 0.09 DBMET03655 0.178 0.135 DBMET03657 0.252 0.058 DBMET03656 | DBMET03656 | |
| 0.07 | 0.099 | 0.094 | MAP kinase 9 inhibitor | 0.094 0.068 DBMET03655 | DBMET03655 | |
| 0.069 | 0.1 | 0.142 | Cyclin-dependent kinase 1 inhibitor | 0.113 0.058 DBMET03655 0.142 0.044 DBMET03656 | DBMET03656 | |
| 0.11 | 0.143 | 0.24 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.199 0.066 DBMET03655 0.24 0.052 DBMET03656 | DBMET03656 | |
| 0.038 | 0.072 | 0.058 | Fibroblast growth factor 4 antagonist | 0.058 0.04 DBMET03655 | DBMET03655 | |
| 0.07 | 0.105 | 0.132 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.132 0.061 DBMET03655 0.124 0.066 DBMET03656 | DBMET03655 | |
| 0.099 | 0.135 | 0.166 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.166 0.062 DBMET03655 0.137 0.086 DBMET03656 | DBMET03655 | |
| 0.099 | 0.138 | 0.24 | CDC-like kinase 2 inhibitor | 0.24 0.049 DBMET03655 0.206 0.063 DBMET03656 | DBMET03655 | |
| 0.018 | 0.061 | 0.028 | Purinergic P2Y14 antagonist | 0.028 0.025 DBMET03656 | DBMET03656 | |
| 0.073 | 0.117 | 0.092 | Cyclin-dependent kinase 2 inhibitor | 0.092 0.08 DBMET03655 0.091 0.081 DBMET03656 | DBMET03655 | |
| 0.023 | 0.068 | 0.084 | DNA-dependent protein kinase inhibitor | 0.084 0.008 DBMET03655 0.072 0.01 DBMET03656 | DBMET03655 | |
| 0.071 | 0.117 | 0.118 | Glycogen synthase kinase-3 inhibitor | 0.118 0.063 DBMET03655 0.097 0.082 DBMET03656 | DBMET03655 | |
| 0.04 | 0.086 | 0.068 | Toll-Like receptor 7 antagonist | 0.068 0.048 DBMET03655 | DBMET03655 | |
| 0.074 | 0.121 | 0.17 | c-Src kinase inhibitor | 0.17 0.046 DBMET03655 0.161 0.05 DBMET03656 | DBMET03655 | |
| 0.044 | 0.093 | 0.065 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.065 0.059 DBMET03655 | DBMET03655 | |
| 0.181 | 0.233 | 0.217 | Ca(v)3.3 blocker | 0.217 0.158 DBMET03655 | DBMET03655 | |
| 0.089 | 0.142 | 0.134 | CDC-like kinase 1 inhibitor | 0.134 0.082 DBMET03655 | DBMET03655 | |
| 0.057 | 0.112 | 0.09 | MAP-kinase-activated kinase inhibitor | 0.09 0.049 DBMET03655 0.081 0.061 DBMET03656 | DBMET03655 | |
| 0.079 | 0.136 | 0.183 | Lck kinase inhibitor | 0.183 0.048 DBMET03655 0.149 0.066 DBMET03656 | DBMET03655 | |
| 0.066 | 0.124 | 0.152 | Vascular endothelial growth factor antagonist | 0.152 0.054 DBMET03655 0.112 0.073 DBMET03656 | DBMET03655 | |
| 0.059 | 0.12 | 0.082 | Check point kinase 2 inhibitor | 0.082 0.081 DBMET03656 | DBMET03656 | |
| 0.072 | 0.136 | 0.27 | Protein kinase (CK1) gamma 2 inhibitor | 0.266 0.017 DBMET03655 0.27 0.016 DBMET03656 | DBMET03656 | |
| 0.084 | 0.148 | 0.285 | Protein kinase (CK1) gamma inhibitor | 0.282 0.022 DBMET03655 0.285 0.021 DBMET03656 | DBMET03656 | |
| 0.032 | 0.097 | 0.046 | Histamine H4 receptor antagonist | 0.046 0.039 DBMET03656 | DBMET03656 | |
| 0.052 | 0.117 | 0.092 | AXL receptor tyrosine kinase inhibitor | 0.092 0.046 DBMET03655 0.079 0.062 DBMET03656 | DBMET03655 | |
| 0.037 | 0.103 | 0.073 | 5 Hydroxytryptamine 3A antagonist | 0.073 0.039 DBMET03655 | DBMET03655 | |
| 0.055 | 0.122 | 0.141 | Vascular endothelial growth factor 2 antagonist | 0.141 0.052 DBMET03655 0.1 0.071 DBMET03656 | DBMET03655 | |
| 0.053 | 0.122 | 0.097 | Insulin like growth factor 1 antagonist | 0.097 0.044 DBMET03655 0.077 0.065 DBMET03656 | DBMET03655 | |
| 0.044 | 0.114 | 0.127 | Fibroblast growth factor 3 antagonist | 0.127 0.021 DBMET03655 0.072 0.062 DBMET03656 | DBMET03655 | |
| 0.046 | 0.116 | 0.073 | MAP-kinase-activated kinase 2 inhibitor | 0.073 0.053 DBMET03655 | DBMET03655 | |
| 0.022 | 0.095 | 0.05 | MAP3K5 inhibitor | 0.05 0.012 DBMET03655 0.043 0.02 DBMET03656 | DBMET03655 | |
| 0.154 | 0.228 | 0.263 | Immunomodulator | 0.263 0.105 DBMET03655 0.223 0.138 DBMET03656 | DBMET03655 | |
| 0.051 | 0.128 | 0.102 | Insulin growth factor antagonist | 0.102 0.045 DBMET03655 0.083 0.063 DBMET03656 | DBMET03655 | |
| 0.041 | 0.119 | 0.077 | Corticotropin releasing factor 2 receptor antagonist | 0.077 0.02 DBMET03655 0.056 0.055 DBMET03656 | DBMET03655 | |
| 0.027 | 0.105 | 0.075 | Toll-Like receptor 8 antagonist | 0.075 0.02 DBMET03655 | DBMET03655 | |
| 0.045 | 0.129 | 0.099 | Bcr-Abl kinase inhibitor | 0.093 0.048 DBMET03655 0.099 0.042 DBMET03656 | DBMET03656 | |
| 0.059 | 0.143 | 0.219 | Protein kinase (CK1) delta inhibitor | 0.219 0.023 DBMET03655 0.201 0.028 DBMET03656 | DBMET03655 | |
| 0.117 | 0.205 | 0.152 | Death-associated protein kinase 2 inhibitor | 0.152 0.101 DBMET03657 | DBMET03657 | |
| 0.04 | 0.129 | 0.114 | Protein kinase B alpha inhibitor | 0.114 0.022 DBMET03655 0.108 0.025 DBMET03656 | DBMET03655 | |
| 0.02 | 0.111 | 0.05 | Glutamate (mGluR1a) antagonist | 0.05 0.021 DBMET03655 | DBMET03655 | |
| 0.012 | 0.106 | 0.045 | 5 Hydroxytryptamine 2C agonist | 0.045 0.032 DBMET03655 | DBMET03655 | |
| 0.082 | 0.18 | 0.114 | Interleukin 2 antagonist | 0.114 0.055 DBMET03655 0.111 0.06 DBMET03656 | DBMET03655 | |
| 0.076 | 0.175 | 0.28 | Activin receptor-like kinase 2 inhibitor | 0.28 0.015 DBMET03655 0.229 0.026 DBMET03656 | DBMET03655 | |
| 0.044 | 0.144 | 0.101 | Fibroblast growth factor 1 antagonist | 0.101 0.057 DBMET03655 0.079 0.075 DBMET03656 | DBMET03655 | |
| 0.103 | 0.204 | 0.202 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.172 0.094 DBMET03655 0.202 0.074 DBMET03656 | DBMET03656 | |
| 0.055 | 0.159 | 0.126 | Aurora-B kinase inhibitor | 0.126 0.06 DBMET03655 | DBMET03655 | |
| 0.024 | 0.131 | 0.058 | mTOR inhibitor | 0.058 0.03 DBMET03655 | DBMET03655 | |
| 0.058 | 0.168 | 0.223 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.173 0.05 DBMET03655 0.223 0.035 DBMET03656 | DBMET03656 | |
| 0.05 | 0.164 | 0.154 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.149 0.048 DBMET03655 0.154 0.045 DBMET03656 | DBMET03656 | |
| 0.05 | 0.163 | 0.154 | Abl kinase inhibitor | 0.149 0.048 DBMET03655 0.154 0.045 DBMET03656 | DBMET03656 | |
| 0.008 | 0.124 | 0.045 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.041 0.013 DBMET03655 0.045 0.011 DBMET03656 | DBMET03656 | |
| 0.031 | 0.151 | 0.052 | Antiviral (Hepatitis D) | 0.052 0.034 DBMET03655 | DBMET03655 | |
| 0.183 | 0.305 | 0.321 | MAP kinase kinase 6 inhibitor | 0.226 0.225 DBMET03654 0.279 0.156 DBMET03655 0.321 0.116 DBMET03656 | DBMET03656 | |
| 0.069 | 0.192 | 0.212 | Protein kinase C nu inhibitor | 0.212 0.043 DBMET03655 0.135 0.079 DBMET03656 | DBMET03655 | |
| 0.065 | 0.19 | 0.261 | Sodium channel blocker | 0.261 0.016 DBMET03655 0.118 0.086 DBMET03656 | DBMET03655 | |
| 0.054 | 0.18 | 0.091 | Phosphodiesterase 7B inhibitor | 0.091 0.068 DBMET03655 | DBMET03655 | |
| 0.046 | 0.175 | 0.184 | Polo-like kinase-4 inhibitor | 0.17 0.025 DBMET03655 0.184 0.02 DBMET03656 | DBMET03656 | |
| 0.077 | 0.207 | 0.26 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.26 0.041 DBMET03655 0.21 0.069 DBMET03656 | DBMET03655 | |
| 0.021 | 0.154 | 0.062 | EphB4 antagonist | 0.062 0.036 DBMET03655 | DBMET03655 | |
| 0.04 | 0.173 | 0.113 | MAP kinase kinase kinase inhibitor | 0.113 0.055 DBMET03655 | DBMET03655 | |
| 0.135 | 0.273 | 0.202 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.202 0.155 DBMET03656 | DBMET03656 | |
| 0.05 | 0.188 | 0.215 | Protein kinase (CK1) inhibitor | 0.215 0.035 DBMET03655 0.206 0.038 DBMET03656 | DBMET03655 | |
| 0.01 | 0.15 | 0.038 | Vascular adhesion protein 1 inhibitor | 0.038 0.028 DBMET03655 | DBMET03655 | |
| 0.06 | 0.2 | 0.246 | Sodium channel (voltage-gated) blocker | 0.246 0.016 DBMET03655 0.126 0.078 DBMET03656 | DBMET03655 | |
| 0.032 | 0.18 | 0.135 | TIE antagonist | 0.135 0.026 DBMET03655 0.107 0.037 DBMET03656 | DBMET03655 | |
| 0.031 | 0.179 | 0.131 | TIE-2 antagonist | 0.131 0.026 DBMET03655 0.103 0.038 DBMET03656 | DBMET03655 | |
| 0.049 | 0.201 | 0.119 | Glutamate receptor antagonist | 0.119 0.074 DBMET03656 | DBMET03656 | |
| 0.071 | 0.224 | 0.253 | TRKC antagonist | 0.253 0.047 DBMET03655 0.251 0.048 DBMET03656 | DBMET03655 | |
| 0.086 | 0.248 | 0.196 | Death-associated protein kinase 3 inhibitor | 0.164 0.103 DBMET03655 0.196 0.077 DBMET03656 | DBMET03656 | |
| 0.047 | 0.209 | 0.165 | Vascular endothelial growth factor 3 antagonist | 0.165 0.057 DBMET03655 0.136 0.079 DBMET03656 | DBMET03655 | |
| 0.029 | 0.199 | 0.077 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.077 0.076 DBMET03655 | DBMET03655 | |
| 0.034 | 0.217 | 0.091 | Cyclin-dependent kinase 5 inhibitor | 0.091 0.084 DBMET03656 | DBMET03656 | |
| 0.074 | 0.269 | 0.236 | I kappa B kinase epsilon inhibitor | 0.236 0.045 DBMET03655 0.216 0.058 DBMET03656 | DBMET03655 | |
| 0.017 | 0.215 | 0.096 | Diacylglycerol O-acyltransferase inhibitor | 0.087 0.011 DBMET03655 0.096 0.008 DBMET03656 | DBMET03656 | |
| 0.045 | 0.246 | 0.089 | MAP kinase kinase 7 inhibitor | 0.089 0.026 DBMET03656 | DBMET03656 | |
| 0.04 | 0.242 | 0.086 | Insulin receptor antagonist | 0.086 0.084 DBMET03656 | DBMET03656 | |
| 0.024 | 0.226 | 0.117 | Nav1.7 sodium channel blocker | 0.117 0.018 DBMET03655 | DBMET03655 | |
| 0.064 | 0.269 | 0.158 | Protein kinase (CK1) gamma 3 inhibitor | 0.154 0.085 DBMET03655 0.158 0.081 DBMET03656 | DBMET03656 | |
| 0.059 | 0.278 | 0.295 | LIM domain kinase 1 inhibitor | 0.295 0.022 DBMET03655 0.294 0.022 DBMET03656 | DBMET03655 | |
| 0.053 | 0.28 | 0.162 | Protein kinase (CK1) gamma 1 inhibitor | 0.157 0.064 DBMET03655 0.162 0.06 DBMET03656 | DBMET03656 | |
| 0.072 | 0.313 | 0.251 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.221 0.063 DBMET03655 0.251 0.051 DBMET03656 | DBMET03656 | |
| 0.022 | 0.276 | 0.058 | Factor IXa inhibitor | 0.058 0.029 DBMET03655 0.049 0.038 DBMET03656 | DBMET03655 | |
| 0.037 | 0.309 | 0.183 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.151 0.088 DBMET03655 0.183 0.072 DBMET03656 | DBMET03656 | |
| 0.07 | 0.343 | 0.234 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.232 0.07 DBMET03655 0.234 0.069 DBMET03656 | DBMET03656 | |
| 0.015 | 0.291 | 0.033 | ATR kinase inhibitor | 0.033 0.022 DBMET03655 0.031 0.029 DBMET03656 | DBMET03655 | |
| 0.029 | 0.31 | 0.068 | Phosphodiesterase VIII inhibitor | 0.068 0.059 DBMET03655 | DBMET03655 | |
| 0.07 | 0.364 | 0.159 | Focal adhesion kinase 2 inhibitor | 0.159 0.117 DBMET03655 | DBMET03655 | |
| 0.088 | 0.397 | 0.193 | Vasodilator, peripheral | 0.193 0.184 DBMET03655 | DBMET03655 | |
| 0.036 | 0.345 | 0.223 | Beta amyloid protein antagonist | 0.223 0.011 DBMET03655 0.142 0.047 DBMET03656 | DBMET03655 | |
| 0.048 | 0.358 | 0.17 | Cyclin-dependent kinase 8 inhibitor | 0.162 0.068 DBMET03655 0.17 0.061 DBMET03656 | DBMET03656 | |
| 0.037 | 0.352 | 0.161 | Dyrk kinase inhibitor | 0.161 0.126 DBMET03655 0.157 0.129 DBMET03656 | DBMET03655 | |
| 0.038 | 0.357 | 0.179 | Nav1.5 sodium channel blocker | 0.179 0.017 DBMET03655 0.108 0.072 DBMET03656 | DBMET03655 | |
| 0.127 | 0.449 | 0.195 | MAP kinase kinase 3 inhibitor | 0.195 0.137 DBMET03655 0.193 0.144 DBMET03656 | DBMET03655 | |
| 0.006 | 0.336 | 0.036 | Protein kinase (CK1) epsilon inhibitor | 0.036 0.035 DBMET03655 | DBMET03655 | |
| 0.032 | 0.367 | 0.146 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.146 0.134 DBMET03656 | DBMET03656 | |
| 0.025 | 0.36 | 0.093 | GABA A receptor agonist | 0.093 0.045 DBMET03655 | DBMET03655 | |
| 0.036 | 0.372 | 0.115 | Toll-Like receptor antagonist | 0.115 0.092 DBMET03655 | DBMET03655 | |
| 0.008 | 0.395 | 0.048 | GABA A receptor antagonist | 0.048 0.044 DBMET03655 | DBMET03655 | |
| 0.002 | 0.426 | 0.019 | Adenosine kinase inhibitor | 0.019 0.017 DBMET03656 | DBMET03656 | |
| 0.017 | 0.507 | 0.118 | GABA receptor agonist | 0.118 0.058 DBMET03655 | DBMET03655 | |
| 0.042 | 0.543 | 0.129 | CF transmembrane conductance regulator agonist | 0.129 0.12 DBMET03655 | DBMET03655 | |
| 0.024 | 0.528 | 0.16 | Heat shock protein 90 alpha antagonist | 0.16 0.077 DBMET03656 | DBMET03656 | |
| 0.008 | 0.547 | 0.051 | Adenosine deaminase inhibitor | 0.051 0.03 DBMET03656 | DBMET03656 | |
| 0.018 | 0.622 | 0.147 | Heat shock protein 90 antagonist | 0.12 0.114 DBMET03655 0.147 0.078 DBMET03656 | DBMET03656 | |
| 0.009 | 0.624 | 0.068 | Heat shock protein 90 beta antagonist | 0.058 0.043 DBMET03655 0.068 0.03 DBMET03656 | DBMET03656 | |
| 0.023 | 0.72 | 0.094 | Adenylate kinase inhibitor | 0.094 0.079 DBMET03656 | DBMET03656 | |
| 0.015 | 0.725 | 0.085 | NADH dehydrogenase inhibitor | 0.085 0.064 DBMET03656 | DBMET03656 | |
| 0.013 | 0.732 | 0.151 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.151 0.147 DBMET03656 | DBMET03656 | |
| 0.004 | 0.734 | 0.053 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.053 0.044 DBMET03656 | DBMET03656 | |
| 0.01 | 0.793 | 0.213 | DNA synthesis inhibitor | 0.213 0.104 DBMET03656 | DBMET03656 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |